You are here

Eli Lilly

Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial

BioPharma Dive

Wed, 12/4/24 - 11:02 am

clinical trials

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Pharma Live

Tue, 12/3/24 - 11:36 am

Four oral GLP-1R products in Phase III trials as race intensifies

Clinical Trials Arena

Tue, 12/3/24 - 11:17 am

Jiangsu Hengrui

clinical trials

Why Amgen's Weight Loss Result Is a Win for Eli Lilly

Motley Fool

Wed, 11/27/24 - 11:30 am

Biden proposes Medicare and Medicaid cover weight loss drugs

Axios

Tue, 11/26/24 - 09:51 am

Pfizer led industrywide sales surge in Q3 after several quarters of dominance by Eli Lilly, Novo Nordisk

Fierce Pharma

Mon, 11/25/24 - 11:43 am

Drugmakers and pharmacists battle over who gets to make obesity drugs

NPR

Wed, 11/20/24 - 11:21 am

compounded drugs

Lilly's lipoprotein-blocking heart med posts midstage win, turning up heat on potential AZ showdown

Fierce Biotech

Tue, 11/19/24 - 11:16 am

clinical trials

New Alzheimer's prevention trial receives $74.5 million NIH grant

Drugs.com

Sun, 11/17/24 - 09:22 pm

Alzheimer's disease

clinical trials

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

Xtalks

Fri, 11/15/24 - 11:27 am

Lilly sues US agency over blocking of drug-rebate program

MSN/Reuters

Fri, 11/15/24 - 11:08 am

Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free

Pharma Live

Thu, 11/14/24 - 11:21 am

Pfizer and Lilly’s telehealth prescribing platforms draw Senate scrutiny for ‘potential fraud’

Pharma Voice

Tue, 11/12/24 - 09:49 am

Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in

Pharma Voice

Thu, 11/7/24 - 11:12 am

Vertex Pharmacuticals

Alpine Immune Sciences

Mariana Oncology

Fusion Pharmaceuticals

Longboard Pharmaceuticals

Aliada Therapeutics

FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels

Beckers Hospital Review

Wed, 11/6/24 - 08:01 pm

States slow to cover GLP-1s for weight loss

Axios

Wed, 11/6/24 - 11:37 am

Lilly shares fall as obesity drug sales miss forecasts

BioPharma Dive

Wed, 10/30/24 - 11:52 am

Dueling IL-23 data drop as Lilly, J&J await FDA decisions in Crohn's

First Word Pharma

Mon, 10/28/24 - 06:24 pm

Crohn's Disease

clinical trials

J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups

Fierce Pharma

Fri, 10/25/24 - 11:43 am

plaque psoriasis

atopic dermatits

How Lilly is building a brand people trust

Medical Marketing and Media

Thu, 10/24/24 - 08:20 pm

Pages